INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 28, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 5,834 |
| Feb 28, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 4,605 |
| Feb 26, 2024 |
EVP General Counsel and Secret
Trans History: 181
|
EVP General Counsel and Secret | Form 4 | Other acquisition or disposition | -- | -- | 3,367 |
| Feb 26, 2024 |
EVP General Counsel and Secret
Trans History: 181
|
EVP General Counsel and Secret | Form 4 | Other acquisition or disposition | -- | -- | 355 |
| Feb 26, 2024 |
Director
Trans History: 326
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 750 |
| Feb 26, 2024 |
Director
Trans History: 326
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 400 |
| Feb 26, 2024 |
Director
Trans History: 326
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 1,000 |
| Feb 20, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 628
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 5,889 |
| Feb 20, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 628
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 180,000 |
| Feb 20, 2024 |
Director, Bd. Co-Chair, President & CSO
Trans History: 628
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 121,071 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.